Fiduciary Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$553K Buy
7,073
+182
+3% +$14.7K 0.06% 174
2026
Q1
$597K Buy
6,891
+106
+2% +$10.2K 0.08% 153
2025
Q4
$652K Buy
6,785
+97
+1% +$9.42K 0.09% 138
2025
Q3
$637K Buy
6,688
+377
+6% +$34.7K 0.1% 128
2025
Q2
$560K Buy
6,311
+361
+6% +$30.6K 0.1% 130
2025
Q1
$491K Buy
5,950
+2,466
+71% +$221K 0.11% 126
2024
Q4
$281K Sell
3,484
-54
-2% -$4.67K 0.06% 211
2024
Q3
$312K Buy
3,538
+4
+0.1% +$336 0.07% 199
2024
Q2
$276K Buy
+3,534
New +$290K 0.07% 210

Other funds holding MDT

Fiduciary Financial Group's MDT Position: Q2 2026 in Review

Fiduciary Financial Group increased its Medtronic (MDT) stake by 2.6% in Q2 2026, buying an estimated $14.7K and bringing the position to 7,073 shares worth $553K. The position accounts for 0.06% of the portfolio, ranked #174.

Fiduciary Financial Group first reported a position in MDT in Q2 2024 and has held it in 9 quarters since. The position peaked at $652K in Q4 2025. 959 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Fiduciary Financial Group held 7,073 shares of Medtronic worth $553K as of Q2 2026.
  • Fiduciary Financial Group bought 182 Medtronic shares in Q2 2026, an estimated $14.7K.
  • Medtronic made up 0.06% of Fiduciary Financial Group's portfolio in Q2 2026, its #174 holding.
  • Fiduciary Financial Group first reported a position in Medtronic in Q2 2024 and has held it in 9 quarters since.
  • Fiduciary Financial Group's Medtronic position peaked at $652K in Q4 2025.
  • 959 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Fiduciary Financial Group's 13F filing for Q2 2026, filed 10 Jul 2026.